Compared with whole brain radiation, stereotactic radiation reduces the rates of neurologic deaths in patients with SCLC and ...

Researchers have found a way to rejuvenate the glycocalyx, the “sugar shield” that bolsters the blood-brain barrier. Exciting ...

Walking and other lifestyle habits may slow cognitive decline in APOE ε4 carriers — possibly offering greater benefits than ...

Non-healthcare provider-produced TikTok videos were more likely to focus on a specific post-treatment side effect when than ...

A recent study shows the use of GLP-1 drugs can increase the risk for optic nerve damage in the first year of treatment, ...

The FDA has granted a “Fast Track” designation to rezpegaldesleukin (REZPEG) as a treatment for severe-to-very severe ...

Findings from a recent trial suggest that not all patients with irritable bowel syndrome who believe they’re intolerant to ...

Pegcetacoplan has been approved for the treatment of C3 glomerulopathy or primary immune complex membranoproliferative ...

Early achievement of the lupus low disease activity state, alone or with standard treatment targets, can predict a reduced ...

The patient’s grade 4 bullous pemphigoid emerges despite cabozantinib dose reduction, requiring high-dose corticosteroids and ...

Mirikizumab shows early and sustained efficacy in reducing bowel urgency and achieving remission in patients with moderate-to ...

Rochester, Minnesota, and New York-Presbyterian Hospital-Columbia and Cornell are the top US hospitals for diabetes and endocrinology, as per the latest U.S. News & World Report rankings.